Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.15 (4.62%)
Spread: 0.10 (3.03%)
Open: 3.25
High: 3.40
Low: 3.40
Prev. Close: 3.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

Wed, 03rd Mar 2021 19:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

HSBC Holdings PLC - FTSE 100-listed Asian-focused lender - Intends to issue USD1.00 billion 4.000% perpetual subordinated contingent convertible securities and USD1.00 billion 4.700% perpetual subordinated contingent convertible securities. The 4% securities are callable in 2026, while the 4.7% can be called in 2031. The securities will be listed in Dublin.

----------

Carnival PLC - Miami, Florida-based cruise ship operator - Says Princess Cruises extends pause of cruise vacations on roundtrip Southampton sailings through September 25, 2021. Notes, for UK guests, Princess Cruises will launch a series of new short cruises departing in late summer on Regal Princess and Sky Princess from Southampton that will go on sale later this month. "We share in our guests' disappointment over these cancelled voyages, and we appreciate the continued understanding and cooperation from our loyal guests and travel advisors," said Jan Swartz, president of Princess Cruises. "As we prepare our ships for a return to service, we remain in close contact with the UK government to monitor the latest travel guidance for international guests."

----------

Capita PLC - FTSE 250-listed London-headquartered outsourcer - Completes sale of Irish Life & Pensions Services to Nasdaq-listed financial technology SS&C Technologies Holdings Inc. The purchase price was not disclosed. CLPSI provides business process management, technology and consultancy services to the international life and pensions sector. The acquisition adds approximately 370 employees in Dublin, Belfast, and Craigforth. The group will continue to focus on Ireland as part of SS&C's Global Investor & Distribution Solutions business.

----------

Daily Mail & General Trust PLC - London-headquartered media company - Buys New Scientist from a consortium of individual investors led by Bernard Gray, for GBP70 million cash consideration. "New Scientist has a large and growing international readership, with a weekly circulation of approximately 120,000, of which just over half are UK-based. The business also has a high-quality revenue base with about 75% derived from subscriptions. In 2021, the business is expected to generate cash operating income and operating profit of approximately GBP7 million and revenues are expected to exceed GBP20 million," company adds.

----------

LSL Property Services PLC - Newcastle-upon-Tyne, England-based estate agency - Agrees option price for the acquisition of the remaining 5% interest in Group First Ltd having initially invested in the company in 2016. The option price has been set at GBP1.4 million with the transaction expected to complete in July 2021. The acquisition will be through LSL's wholly owned subsidiary, your-move.co.uk Ltd.

----------

Cohort PLC - defence and security markets-focussed technology company - Confirms subsidiary Elac Sonar in discussions with an export customer about the provision of submarine sonar systems. "If these discussions are successful, the resulting contract would be significant in relation to the group's order book and would enhance the visibility of future revenues, though it would not materially affect current market expectations of the group's performance," company says.

----------

Real Estate Investors PLC - Midlands-focused real estate investment trust - Refinances existing debt facilities. Company's GBP51 million RBS term loan facilities, due to expire in February 2021, of GBP41 million, and August 2023, of GBP10 million, have been renewed with NatWest Bank for a further three years at 2.25% above LIBOR, with expiry of this facility due in March 2024, secured on a portfolio of the group's properties. The average cost of debt across the group remains at 3.4%.

----------

Allergy Therapeutics PLC - Sussex-based biotechnology firm focused on allergy vaccines - Pretax profit in six months to December 31 down slightly year on to GBP15.6 million. Revenue improves to GBP54.0 million from GBP50.5 million. Administrative expenses grows to GBP14.3 million from GBP9.5 million. Chief Executive Manuel Llobet says: "The group has made a strong start to the year despite the uncertainty of Covid-19, Brexit and the regulatory and business environment. We continue to perform well commercially with robust growth across all key products in our portfolio and further market share gains thanks to our dedicated workforce. Progressing our growing, high-potential pipeline remains a priority and provides exciting opportunities in the allergy immunotherapy field and the broader immunology space."

----------

Sportech PLC - Edinburgh-based gambling technology firm - Seeking further clarification on US state of Connecticut's proposal to expand gaming, specifically sports wagering and iGaming in a deal with the Mohegan Tribe and the state Lottery. Says announcement is somewhat contrary to the previous statements from the governor of the northeastern state. "The proposal includes 15 retail sports betting locations awarded to the state lottery with a right to sub-license some of those locations to Sportech venues," company says.

----------

Ground Rents Income Fund PLC - real estate investment trust - Net asset value per share ends September at 105.7 pence compared 111.3p at the same point the year before. Portfolio value stable over the period at GBP124.2 million. NAV drop reflects a one-off accounting adjustment relating to the Beetham Tower litigation which is expected to be reversed during the current financial year. Pays total dividends of GBP3.9 million in 2020, unchanged on year before. Chair Malcolm Naish adds: "The board and manager continue to support leasehold reform which achieves a better balance between the interests of ground rent investors and leaseholders, and we are both advocates for a fair and transparent leasehold system which takes account of all stakeholders and supports the appropriate value of the group's portfolio."

----------

finnCap Group PLC - London-based stockbroker - Says it has traded materially ahead of internal expectations in the second half. Expects total income for year ending March 31 in excess of GBP43 million, which would represent a 65% rise year on year. Profits and year-end cash balance to be well ahead of internal expectations. "The capital markets business recorded its highest level of quarterly deal fees in Q3 and continued to enjoy good growth in year-on-year sales and trading revenue. After a quiet Q3, the M&A team in Cavendish has delivered a strong performance to date in Q4 with the successful closure of a number of deals before the announcement of the UK budget," company adds.

----------

GetBusy PLC - document management and productivity software - Pretax loss broadly flat year on year in 2020 at GBP1.1 million. Total revenue improves 12% to GBP14.2 million from GBP12.7 million, as recurring revenue grows 14% to GBP13.0 million. Virtual Cabinet revenue up 2% to GBP8.5 million and SmartValue revenue up 31% to GBP5.7 million. Chief Executive Daniel Rabie says: "n 2021, we expect to continue to capitalise on the trends that have been favourable to us during 2020. We are very clearly in the scaling phase of our document management business comprising SmartVault and Virtual Cabinet, and we are able to see a path to a substantial business with high quality, predictable and valuable earnings in the medium to long term."

----------

Barkby Group PLC - Abingdon-headquartered company with businesses in real estate, consumer & hospitality and life sciences - Says revenue in final six months of 2020 was GBP7.9 million, with earnings before interest, taxes, depreciation and amortization loss of GBP1.1 million and a net loss of GBP2.0 million. Executive Chair Charles Dickson says: "Barkby has weathered the Covid-19 pandemic largely due to the success of our highly cash generative commercial property development business and activity has resumed apace. As we come out of lockdown, our pubs and coffee business are poised for significant growth and a return to profitability. The group's investments in SleepHub and Verso Biosense are performing well. Our liquidity is strong and the diversification of the business means that the group is in a strong position to benefit from the lifting of government lockdown restrictions. We look forward to the next 12 months with confidence."

----------

Premier Miton Global Renewabls Trust PLC - energy, water and infrastructure firm investor - Net asset value per share ends 2020 at 173.48 pence, up from 144.94p at the same point the year before. Annual dividend unchanged year on year at 10.20p. NAV total return in 2020 16.5% compares to FTSE Global Core Infrastructure 50/50 Total Return Index losing 6.1%. "There are a couple of factors relating to the trust's out-performance worth highlighting. Firstly, during the market rout in the first quarter, the manager acted to limit losses by taking a short index futures position against the major markets to which the portfolio was exposed. This gave a cash profit, which was then re-invested into the market at a very attractive entry point, resulting in further gains. In total, equity market hedging gains in the year amounted to GBP2.9 million," company says. It also notes its portfolio, being mainly exposed to contracted and regulated underlying revenue streams, was in reality not as exposed to the economic situation as either the market as a whole.

----------

BlueRock Diamonds PLC - South African-focused diamond miner - Raises gross proceeds of GBP1.5 million via an oversubscribed placing and subscription of 3.8 million new ordinary shares at 40 pence per share. The net proceeds will primarily be used to complete the company's expansion project, at its Kareevlei diamond mine in the Kimberley region of South Africa, to increase annual production to about one million tonnes per annum by early the second quarter of 2021 and provide working capital to cushion against further disruption which has arisen due to excessive rain and Covid-19.

----------

Mosman Oil & Gas Ltd - Australia and US-focused oil & gas explorer - Notes operator of the Falcon-1 well in East Texas, US, has reported a recent increase in water production alongside a fall in pressure at Falcon-1. To manage this, the well head choke size has now been reduced. "These developments have resulted in significantly lower reported oil and gas production rates at Falcon-1. The operator is assessing the situation and has indicated that it intends to run downhole logs to gather more information in order to recommend an appropriate course of action," company adds. Mosman has a 50% working interest in the well.

----------

Fletcher King PLC - London-based chartered surveyors - Expects trading loss in the second half of financial 2021, ending April, which could be similar to first half's loss of GBP447,000. Says transaction-based fees materially lower than would otherwise be expected, blamed on the pandemic. Notes it remains well supported by a strong balance sheet with no debt. "In addition, the company believes that it will be necessary to write down the value of its investment in the SHIPS 16 property syndicate, being an interest in a property in Botolph Lane, London. Two floors in the property remain unlet and prospects for achieving lettings in the current challenging economic environment have been made even more difficult by the return of lockdown measures since December," company adds.

----------

Edenville Energy PLC - operating of the Rukwa coal project in southwest Tanzania - Continues to work with its strategic partner Infrastructure & Logistics Tanzania Ltd regarding the proposed handover of operations at Rukwa. Says it continues to satisfy existing contracts and is pursuing additional contracts with both existing and potential customers. Receives new East African enquiries regarding power generation capacity and is continuing discussions with the Tanzanian government regarding a future power plant development at Rukwa.

----------

Phimedix PLC - Hong Kong-based metal recycling company - Says proposed acquisition in the life sciences space will not now be proceeding. "As no reverse takeover will be completed by March 14, being the date six months following the suspension of trading in the company's shares, the London Stock Exchange will cancel the admission of Phimedix's ordinary shares to trading on AIM with effect from 0730 GMT on Monday March 15," company explains. Adds: "After cancellation, the company will explore its available options, and keep shareholders informed as and when appropriate."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2019 11:26

Allergy Therapeutics Looking To Chinese Market As It Swings To Profit

Allergy Therapeutics Looking To Chinese Market As It Swings To Profit

Read more
27 Jun 2019 10:07

Allergy Therapeutics earnings set to top expectations

(Sharecast News) - Biotechnology group Allergy Therapeutics told investors on Thursday that 2019 full-year earnings looked set to come in ahead of market expectations.

Read more
19 Jun 2019 13:39

Allergy Therapeutics Hires Former Advanced Medical Solutions CFO

(Alliance News) - Allergy Therapeutics PLC on Wednesday said it has appointed Mary Tavener as a non-executive director with immediate effect.The biotechnology company said Tavener has in 19

Read more
20 May 2019 13:42

Allergy Therapeutics Vaccine Helps Dust Mite Allergy Symptoms In Study

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said its Acarovac MPL vaccine improved dust mite allergy symptoms during a phase one study.The AM101 study, which was open-label

Read more
20 May 2019 11:00

Allergy Therapeutics flags positive outcomes from recent treatment trial

(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive Phase 1 safety and tolerability results of subcutaneous 'Acarovac MPL' (monophosphoryl lipid A) in patients with house dust mite-induced allergic rhinoconjunctivitis on Monday.

Read more
25 Apr 2019 10:01

Allergy Therapeutics eyes 2020 start for hay fever inoculation trials

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics will kick off phase III trials of its short-course inoculation for grass pollen-induced hay fever in the second half of 2020 following a successful round of meetings with German and American regulatory bodies.

Read more
18 Mar 2019 10:44

WINNERS & LOSERS SUMMARY: Footasylum Rises On "Generous" JD Offer

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - Tinto, up 2.3%, Group, up in

Read more
18 Mar 2019 10:06

Allergy Therapeutics Surprised As Vaccine Trial Fails Primary Endpoint

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said a phase three trial of its birch pollen allergy vaccine did not meet its primary endpoint.Shares in Allergy Therapeutics 43%

Read more
18 Mar 2019 08:51

Allergy Therapeutics shares plunge after disappointing clinical trial

(Sharecast News) - Shares in biotechnology company Allergy Therapeutics were plunging on Monday morning, after it announced disappointing top-line results from the phase 3 clinical trial 'B301' of its new adjuvanted birch allergoid product.

Read more
6 Mar 2019 11:13

Allergy Therapeutics Interim Profit Rises 67% On Higher Revenue

LONDON (Alliance News) - Allergy Therapeutics PLC on Wednesday reported significantly higher profit for the first six months of its financial year as revenue rose and research costs were the to of

Read more
6 Mar 2019 10:19

Allergy Therapeutics profits rise as it spends less on R&D

(Sharecast News) - Specialty pharmaceutical group Allergy Therapeutics announced its unaudited interim results for the six months ended 31 December on Wednesday, reporting a 10.6% improvement in revenue on both a reported and constant currency basis, to £46.7m.

Read more
16 Jan 2019 12:26

Allergy Therapeutics First Half Meets Forecasts On European Growth

LONDON (Alliance News) - Allergy immunology vaccines developer Allergy Therapeutics PLC said Wednesday trading in the first half was in line with expectations.Allergy Therapeutics expects -

Read more
16 Jan 2019 08:51

Allergy Therapeutics sees good first-half progress

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics updated the market for the six months ended 31 December on Wednesday, reporting that it was trading in line with board expectations.

Read more
27 Nov 2018 13:12

Allergy Therapeutics Continues To Perform Well, Revenue Up "Strongly"

LONDON (Alliance News) - Allergy Therapeutics PLC said Tuesday it has continued to perform well, with revenue up "strongly" from the prior year and sales in line with market financial to

Read more
27 Nov 2018 10:05

Allergy Therapeutics boosted by strong German performance

(Sharecast News) - Biotechnology company Allergy Therapeutics has seen revenues increase throughout the first half of its trading year thanks to an improved market share for its allergy vaccines on the continent.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.